ArticleGynecologic oncology reports2024

Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series.

Shannon M Glynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.